Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 136 Records) |
Query Trace: Myelofibrosis and MPL[original query] |
---|
[Clinical impact of gene mutations on myeloproliferative neoplasms in Japan]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 9 62 (8): 1060-1069. Morishita So |
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients. American journal of hematology 2021 Aug . Loscocco Giuseppe G, Guglielmelli Paola, Gangat Naseema, Rossi Elena, Mannarelli Carmela, Betti Silvia, Maccari Chiara, Ramundo Francesco, Jadoon Yamna, Gesullo Francesca, Ceglie Sara, Paoli Chiara, Pardanani Animesh, De Stefano Valerio, Tefferi Ayalew, Vannucchi Alessandro |
Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN). International journal of environmental research and public health 2021 Jul 18 (14): . Zulkeflee Razan Hayati, Zulkafli Zefarina, Johan Muhammad Farid, Husin Azlan, Islam Md Asiful, Hassan Rosli |
JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East. Iranian journal of pathology 2021 5 16 (2): 190-194. Safavi Moeinadin, Monabati Ahmad, Safaei Akbar, Mirtalebi Maryam Sadat, Faghih Masoum |
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study. Frontiers in oncology 2021 4 11 637116. Cattaneo Daniele, Croci Giorgio Alberto, Bucelli Cristina, Tabano Silvia, Cannone Marta Giulia, Gaudioso Gabriella, Barbanti Maria Chiara, Barbullushi Kordelia, Bianchi Paola, Fermo Elisa, Fabris Sonia, Baldini Luca, Gianelli Umberto, Iurlo Alessand |
Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India. Hematology/oncology and stem cell therapy 2021 3 15 (2): 13-20. Maddali Madhavi, Kulkarni Uday Prakash, Ravindra Niveditha, Arunachalam Arun Kumar, Venkatraman Arvind, Lionel Sharon, Manipadam Marie Therese, Devasia Anup J, Korula Anu, Fouzia N A, Abraham Aby, Srivastava Alok, George Biju, Balasubramanian Poonkuzhali, Mathews Vikr |
MPL exon 10 mutations other than canonical MPL W515L/K mutations identified by in-house MPL exon 10 direct sequencing in essential thrombocythemia. International journal of hematology 2021 3 113 (5): 618-621. Sugimoto Yuka, Nagaharu Keiki, Ohishi Kohshi, Nakamura Maki, Ikejiri Makoto, Nakatani Kaname, Mizutani Minoru, Tamaki Shigehisa, Ikeda Takeshi, Tawara Isao, Katayama Naoyu |
Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges. Clinical lymphoma, myeloma & leukemia 2021 3 21 (6): e569-e578. Singh Suvir, Kaur Komalpreet, Paul Davinder, Jain Kunal, Singh Jagdeep, Narang Vikram, Garg Bhavna, Sood Neena, Dhillon Barjinderj |
Development of a Real-Time qPCR Assay for Detection of Common MPL Mutations in Myeloproliferative Neoplasms (MPNS). Applied biochemistry and biotechnology 2022 7 194 (12): 5907-5917. Ullah Naeem, Khan Sadiq Noor, Umair Muhammad, Khan Aamir Ali, Liu Xinhui, Khattak Aamer Ali, Yousafzai Yasar Mehmo |
Targeted sequencing of candidate gene regions for myelofibrosis in dogs. Journal of veterinary internal medicine 2022 7 36 (4): 1237-1247. Campbell Amelia G, Seelig Davis M, Beckman Joan D, Minor Katie M, Heinrich Daniel A, Friedenberg Steven G, Modiano Jaime F, Furrow E |
Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms. Asian Pacific journal of cancer prevention : APJCP 2022 5 23 (5): 1671-1678. Wiriyaukaradecha Kriangpol, Nimsanor Supanee, Tantirukdham Nithiphut, Tongsom Jin, Bunyoo Chakrit, Soonklang Kamonwan, Sritana Narongrit, Auewarakul Chira |
Lab tests for MPN. International review of cell and molecular biology 2022 2 366 187-220. Moncada Alice, Pancrazzi Alessand |
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels. Annals of hematology 2022 Oct . Lewandowski Krzysztof, Kandu?a Zuzanna, Gniot Micha?, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Micha?, Mariak Magdalena, Handschuh Luiza, Kozlowski Pio |
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia. Hematology reports 2022 Aug 14 (3): 265-269. Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg |
The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype. Frontiers in oncology 2023 9 13 1224590. Patryk Sobieralski, Bartosz Was?g, Aleksandra Leszczy?ska, Monika ?uk, Maria Bieniaszews |
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. Frontiers in oncology 2023 8 13 1190305. Helna Pettersson, Jenni Adamsson, Peter Johansson, Staffan Nilsson, Lars Palmqvist, Björn Andréasson, Julia A |
Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN. Frontiers in genetics 2023 7 14 1198834. Jin Zhang, Kefeng Shen, Min Xiao, Jinjin Huang, Jin Wang, Yaqin Wang, Zhenya Ho |
JAK2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients. Hematology/oncology and stem cell therapy 2023 4 16 (3): 303-314. Shires Karen L, Rust Adriana J, Harryparsad Rushil, Coburn Justin A, Gopie Ruth |
Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan. American journal of clinical pathology 2023 3 . Kuo Ming-Chung, Chuang Wen-Yu, Chang Hung, Lin Tung-Huei, Wu Jin-Hou, Lin Tung-Liang, Ou Che-Wei, Hung Yu-Shin, Huang Ting-Yu, Huang Ying-Jung, Wang Po-Nan, Shih Lee-Yu |
Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (3): 100016. Al-Ghamdi Yahya A, Lake Jonathan, Bagg Adam, Thakral Beenu, Wang Sa A, Bueso-Ramos Carlos, Masarova Lucia, Verstovsek Srdan, Rogers Heesun J, Hsi Eric D, Gralewski Jonathon H, Chabot-Richards Devon, George Tracy I, Rets Anton, Hasserjian Robert P, Weinberg Olga K, Parilla Megan, Arber Daniel A, Padilla Osvaldo, Orazi Attilio, Tam Way |
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older: a study from the German Registry for Stem Cell Transplantation. Transplantation and cellular therapy 2024 8 . Nico Gagelmann, Claudia Schuh, Robert Zeiser, Matthias Stelljes, Wolfgang Bethge, Gerald Wulf, Daniel Teschner, Stefan Klein, Eva Wagner-Drouet, Edgar Jost, Peter Dreger, Sarah Flossdorf, Nicolaus Krög |
Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 2024 1 14 (1): 11. Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Teffe |
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 2024 1 14 (1): 10. Giuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M Vannucchi, Paola Guglielmel |
- Page last reviewed:Feb 1, 2024
- Content source: